INTRODUCTION
Virechana is therapeutic purgation indicated for multiple conditions like Pittaja vyadhi (~disorders of pitta), Kushta (~skin diseases), Meha (~diabetes), Udara (~ascites), Pandu (~anemia), Hridroga (~cardiacdiseases), Vyanga (~pigmentation diseases), Swasa (~asthmaticconditions), K a s a (~ch r o n i c c o u g h ) , K a m a l a (~j a u n d i c e ) , Apasmara (~epilepsy), Unmade (~psychic disorders), Vatarakta (~gout), Yoni roga (~gynecological disorders). For example, KLE Ayur veda Hospital Database has recorded total 714 Virechana procedures in the year 2014. Virechana has also been studied extensively by various researches and proven as efficacious over Shamana (palliative) type of treatment in various conditions like Tamakashwasa [1] (~bronchial asthma), essential hypertension. [2] Studies have also reported that Virechana found to be effective in curing and preventing the recurrence of Vicharchika [3] (~eczema). Virechana was also found to be beneficial in chronic conditions like obese patients with Prameha (~type-2diabetes). [4] Comparative studies have also been conducted with two different purgative medicines to assess its efficacy on psoriasis.
Numerous drugs have been described for Virechana. Critical analysis of these drugs with reference to their pharmacological actions and disease-specific formulations has been narrated. Different classifications of Virechaka dravyas were also mentioned in the literature depending on their action [5] (Virechaka and Virechakopaga), part [6] and potency [7] of the drug used. Dose of these drugs has been decided depending on the form administered (powder/linctus/decoction etc.) which further depends on the type of Koshta (~gastrointestinal tract). [8] Even with all these critical inputs, there is difficulty in the fixation of dose within the patients of similar Koshta and varied output (Vegas) of Virechana is observed. Danti (Baliospermum montanum) is the least practiced purgative drug as a prime medicine. The data with evidence provide authentic information for clinical application and practice of Panchakarma. Hence, the analysis of varied outcomes of Virechana with Danti avaleha administered to the patients at Department of Panchakarma, KLE Ayurveda hospital, Belgaum, has been discussed in this paper.
MATERIALS AND METHODS
The present study is a retrospective study of case report formats of patients who have undergone Virechana with Danti Avalehya in Department of Panchakarma, KLE Ayurveda Hospital, Belgaum.
Source of data
Outpatient department and inpatient department case report formats available at Department of Panchakarma, KLE Ayurveda Hospital, Belgaum.
Selection of case reports
Completed case reports of patients, who had undergone Virechana by Danti avaleha, are selected for the study. Total number of patients undergone Virechana were 30, but only 27 case reports were complete with all details which were selected in this retrospective study.
Case reports presented that patients have undergone prior evaluation for fitness of Virechana in the Panchakarma department. Hence, the patients with pathological conditions of Annavaha Srotas like Shoola (~acid-peptic disorders, gastric ulcer, acute gastritis, cholilitheasis), Bhagandhara (~acute fissure and fistula) were ruled out before administration of Virechana procedure as Teekshana virechana has been advised.
Exclusion of case reports
Incomplete case report formats, where complete details of Virechana vegas and type of Shuddhi have not been mentioned and case reports of patients who discontinued Virechana procedure because of aversion to Snehapana, were excluded from the study.
Duration of study
All the case reports of the patients collected were in the span of 18 months (December 2012-April 2014).
Procurement of Danti avaleha
Danti avaleha administered for the patients during this period was procured from GMP certified KLE Ayurveda Pharmacy, Belgaum. The medicine used for all the patients was prepared in a single batch with shelf life of 24 months.
Statistical methods like simple average and percentage analysis were used in this study.
Assessment of Shuddhi
Shuddhi is defined as the effect resulted in the patient due to the expulsion of doshas (morbid factors) by administration of Panchakarma procedures. The following two parameters are primarily considered to assess the type of Shuddhi.
Vegiki/grading of Shuddhi
Shuddhi attained by Virechana is graded into three types depending on the number of purgative bouts after the omission of first two bouts passed initially. Passage of bouts ranging from 1 to 10, 11 to 20, and 21 to 30 is graded as avara (least), madhyama (medium), and Pravara (excellent) type of Shuddhi.
Kapha Aantiki shuddhi
Aantiki shuddhi means type of Dosha expelled during end of Virechana vegas (purgative bouts). Here, Kapha dosha is expected to be Aantiki shuddhi which is prime sign for deciding the Samyak yoga of Virechana (perfect purgation), apart from the number of bouts.
As per the case reports, all 27 patients were administered initially with Deepana (carminatives) and Pachana (digestives) with Chitrkadivati till Nirama lakshanas were observed. Later, Snehapana (internal oleation) was administered with Moorchita gritha (processed ghee) till the attainment of Samyak snigdha lakshanas (proper signs of unctuousness). During the next 3 days of Vishrama kala, Sarvanga abhyanga (external oleation) with Moorchita tila taila (processed sesame oil) followed by Bashpa sweda (sudation) were administered. Finally, all the patients were administered Virechana with Danti avaleha in the dose of 5 g and 10 g for Madhyama and Krura koshta, respectively. In the patients where Ayoga lakshanas (improper purgation) were observed, Danti avlehya was re-administered at the dose of 5 g after assessing their Jeerna aushadhi lakshanas (signs of digestion of previous dose of medicine).
Observations
Case reports presented that the patients were diagnosed with irregular menstrual cycles, polycystic ovarian syndrome (11), primary and secondary infertility (6) , and psoriasis (10) .
None of the case reports suggested past history of diabetes in the patients. Study revealed that patients who were fit for Teekshana (severe) Virechana were only administered Virechana with Danti avaleha. The age of the patients in the reports was found to be in the range of 20-40 years.
RESULTS OF THE STUDY
Among 27 patients, seven of them possess Krura koshta, and twenty possess Madhyama koshta. Krura koshta patients attained Snigdhata (unctuousness) in 6 days with average dose of 215 ml, whereas Madhyama koshta group attained Snigdhata in span of 4 days with average dose of 180 ml. Signs of unctuousness were observed in all patients [ Table 1 ].
Among Krura koshta, three patients had Pravara shuddhi whereas four patients had Madhyama shuddhi with minimum of 15 and maximum of 24 bouts. Among Madhyama koshta patients, four had Madhyama shuddhi whereas 16 had Avara shuddhi with minimum of 6 and maximum of 14 bouts. Kaphantika lakshana was observed in all patients irrespective of Koshta [ Table 2 ].
Udarashoola and Vamana were the complications observed in the patients on the day of Virechana. Udarashoola has been experienced by three Krura koshta and seventeen Madhyama koshta patients. Vamana was observed in four Krura koshta and sixteen Madhyama koshta patients.
Four Krura koshta patients who encountered vamana complication were of Kaphapitta prakriti and had Madhyama shuddhi. While other three did not have vamana and attained Pravara shuddhi.
In Madhyama koshta, sixteen patients had Vamana of which four attained Madhyama shuddhi and 12 attained Avara shuddhi. While other four attained Avara shuddhi only, without the complication of Vamana [ Table 3 ].
Punah oushadi prayoga (re-administration of medicine) was observed in all Madhyama koshta patients [ Table 3 ].
This study also observed that the patients had undergone Virechana in different months and presented with different types of Shuddhi which was not season-dependent. The above data depict that the three types of Shuddhi are present in all the seasons which does not vary much.
DISCUSSION
Danti is one among best six purgative drugs mentioned in our classics. Danti possesses the qualities like Teekshana (sharp), Ushna (hot), Guiru (heavy), Aashukari (faster in action), Vikasi (relieves obstruction). This is more beneficial in reducing pitta and Kapha doshas. [9] Virechana with Danti is mainly indicated in Gulma (growth), Udara (ascites), Granthi (cysts), Aavrita vata (complex pathological conditions of Vata), Aartava dhushti (menstrual disorders), kushta (skin disorders) [10] and in the conditions where Teekshana virechana [11] (strong purgation) is advised. This drug can be administered as a purgative in all seasons. [12] In spite of many indications, still this drug is used as only an ingredient in many formulations like Kaishora guggulu, chandraprabha vati etc., rather than as a purgative drug. This may be due to the above complications like Udara shoola and Vamana. Intolerance of the drug was experienced by the patients when administered for purgation and even there is difficulty in the fixation of dose also. Hence, this retrospective study was performed to understand the common dose of Danti avaleha administered and the presentation of bouts.
This study shows that the duration of Snehapana and quantity of Sneha consumed with respect to the Koshta are almost similar to earlier studies on Samyak snigdha lakshanas. [13] The earlier studies also presented the duration 
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Vamana complication observed in general after first Vega of Virechana. In all Madhyama koshta patients, punah virechana aushada was administered at the dose of 5 g when ayoga was observed. Number of patients in parenthesis of Snehapana in the same range of 6-7 days for Krura koshta patients and 4-5 days in Madhyama koshta patients. In this study, the percentage of patients those attained Samyak snigdha lakshanas like Shakhagata (oleation of peripheral tissues/exterior tissues)/Twacha snigdha (uctousness of skin), Koshtagata (oleation at Gastrointestinal tract [GIT])/Purisha snigdha (slimy stools with fat), and Snehodvega (aversion to Sneha) with respect to koshta were in parity with previous studies [ Table 1 ]. [13] The age of the patients in the case reports was in the range of 20-40 years where the dose of medicine remains standard. Hence, the dose of Danti avaleha administered in these patients was not age-dependent but based on type of Koshta.
Pravara shuddhi was observed only in Krura koshta patients, whereas Madhyama shuddhi was noticed in both Krura and Madhyama koshta patients. Avara shuddhi was seen only in patients of Madhyama koshta. The purgative bouts observed in Krura koshta were in the range of 15-24, whereas the bouts in the Madhyama koshta ranged between 6 and 14. Samyak virikta lakshana of Kaphaanta was attained irrespective to the number of bouts, which might be due to Teekshana (penetrant) and bhedana (purgative) gunas of Danti.
Pravara type of shuddhi was observed in those Krura koshta patients where complete medicine was retained due to the absence of Vamana. That might have caused more number of Vegas resulting in Pravara shuddhi. The other set of Krura koshta patients who attained Madhyama shuddhi may be ranging from Madhyama to Krurata. Hence, they might have vomited due to intolerance of drug and thus produced less number of Vegas resulting in Madhyama type of Shuddhi.
Fur ther analysis has shown that Udara shoola (spasmodic abdomen) was experienced by twenty patients among whom three patients belong to Krura koshta and remaining seventeen belongs to Madhyama koshta. Onset of Udara shoola was observed within 10 min of administration of drug in all twenty patients, and fifteen of them were relieved from pain soon after Vamana. In general, Udarashoola is expected with abnormal dosage, excessive higher dose, improper purification (Shodhana) of the medicine and in conditions like administration of Teekshana dravya in mridu koshta (high potent medicine in mild Koshta). [14] The conditions affecting GIT like acid-peptic disorders, ulcer, acute fissure and fistula etc., were also evaluated. Even in the absence of all the above factors, the occurrence of abdomen pain in patients may be attributed to Teekshana guna of Danti.
Even in the absence of causative factors of Vamana like administration of purgation during Kapha kala (kapha predominance time), Kapha associated conditions and low intensity of agni, [14] the condition "Vamana" was still be observed. This again might be due to Teekshana guna of Dravya leading to spasmodic pain in abdominal muscles with contractions and expulsion of Dravya through oral route. Another important point to be noted is that the Vamana happened in all the patients after their first purgative bout, clearly indicating that emesis was not due to patient's aversion for medicine.
Relation between Shuddhi and the complication Vamana in Krura Koshta: Here, the Koshta is predominant of Vata and Kapha dosha. [15] The patients (3) who did not vomit the drug can be understood as possessing the inherent quality of Krura tama (excess krura/strong) in their Koshta where vata is predominant. Hence, they were able to tolerate Teekshana dravya and had maximum average number of Vegas (22.4). The other four patients might be of Krura tara (moderate strong) with Kapha predominant Koshta and hence vomiting was observed. But still they were able to exert average bouts of sixteen without requiring re-administration of the second dose.
Re-administration of medicine in Madhyama koshta
Madhyama and Avara shuddhi were observed in all Madhyama koshta patients. Among Madhyama koshta, 80% of them presented with the complication of Vamana and remaining 20% did not have Vamana. Avara vegas were observed in all patients irrespective of Vamana complication. The second dose of 5 g medicine was administered only after ascertaining the digestion of previous dose. Even after re-administration of medicine, there was no much improvement in the number of bouts.
The dependence of season on the number of bouts or type of Vegiki shuddhi (end point) is evaluated. It is clearly evident from the data that the three types of Shuddhi were seen in all the seasons. This indicates that Vegiki shuddhi is not related to season and dependent only on the effect of drug.
Further the age of patients was not related to the type of Shuddhi attained. From the observation, it is found that all patients who had undergone Virechana were in the age range of 20-40 years where the dose of drug remains same as per classics. Hence, the type of Shuddhi is more dependent on the quantum of Doshas (morbid factors), rather than age of the patient and their dose.
Danti (Baliospermum montanum) is attributed for possessing the property of hydragogue cathartic. [16] This means it produces a discharge of watery fluid belonging to the class of cathartics that retains fluids in the intestines and aid in the removal of only edematous fluids which can be correlated to bhedana/rechana type of Virechana. Hence, this might have induced the purgation even at mild doses. The difference in the number of bouts may be due to the individual response to the phytochemicals such as baliospermin and montanin, [17, 18] present in Danti moola, which might be responsible for purgation.
Danti is a least practiced drug for purgation because of the complications like intolerance of the drug, spasmodic abdomen and emesis of the medicine. In spite of these complications, still Kaphaantaki was observed in all the patients of either koshta which is the Samyak virikta lakshana.
CONCLUSION
This study presents the evidence that administration of Danti dravya at dose of 10 g is well-tolerated by patients possessing Krura koshta. Pravara shuddhi may be attained at dose of 10 g in Krura koshta. Madhyama koshta patients were intolerable with dose of 5 g and even after repetition of dose, they resulted only with Madhyama and Avara shuddhi.
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